Total Payments
$3,977
2024 Payments
$257.73
Companies
21
Transactions
109
Medicare Patients
2,333
Medicare Billing
$112,768
Payment Breakdown by Category
Food & Beverage$2,548 (64.1%)
Travel$1,375 (34.6%)
Education$54.00 (1.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,548 | 103 | 64.1% |
| Travel and Lodging | $1,375 | 5 | 34.6% |
| Education | $54.00 | 1 | 1.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic, Inc. | $1,992 | 13 | $0 (2023) |
| Biohaven Pharmaceuticals, Inc. | $383.54 | 9 | $0 (2021) |
| ABBVIE INC. | $290.12 | 20 | $0 (2024) |
| GRT US Holding, Inc. | $280.37 | 7 | $0 (2022) |
| EISAI INC. | $221.53 | 11 | $0 (2022) |
| Collegium Pharmaceutical, Inc. | $199.74 | 12 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $101.55 | 6 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $75.89 | 3 | $0 (2024) |
| Lilly USA, LLC | $71.40 | 5 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $51.07 | 3 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $257.73 | 13 | Teva Pharmaceuticals USA, Inc. ($75.89) |
| 2023 | $2,099 | 20 | Medtronic, Inc. ($1,992) |
| 2022 | $466.71 | 19 | GRT US Holding, Inc. ($247.77) |
| 2021 | $1,153 | 57 | Biohaven Pharmaceuticals, Inc. ($383.54) |
All Payment Transactions
109 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $13.71 | General |
| Category: Central Nervous System | ||||||
| 12/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $25.59 | General |
| Category: Gastroenterology | ||||||
| 10/01/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $17.71 | General |
| Category: Immunology | ||||||
| 09/03/2024 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $15.52 | General |
| Category: Immunology | ||||||
| 07/25/2024 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $18.01 | General |
| Category: Immunology | ||||||
| 07/17/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $20.74 | General |
| Category: IMMUNOLOGY | ||||||
| 07/03/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $13.56 | General |
| Category: Gastroenterology | ||||||
| 06/11/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $16.64 | General |
| Category: Opioid Analgesic | ||||||
| 05/21/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $19.50 | General |
| Category: Opioid Analgesic | ||||||
| 05/09/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $39.45 | General |
| Category: Central Nervous System | ||||||
| 04/17/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $20.39 | General |
| Category: Opioid Analgesic | ||||||
| 03/06/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $22.73 | General |
| Category: Central Nervous System | ||||||
| 01/30/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $14.18 | General |
| Category: Neuropsychiatry | ||||||
| 10/03/2023 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $14.56 | General |
| Category: Opioid Analgesic | ||||||
| 09/07/2023 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $15.31 | General |
| Category: PAIN MANAGEMENT | ||||||
| 08/30/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: Gastroenterology | ||||||
| 06/14/2023 | Medtronic, Inc. | SYNCHROMEDII (Device) | Travel and Lodging | In-kind items and services | $438.00 | General |
| Category: Drug Infusion Systems | ||||||
| 06/14/2023 | Medtronic, Inc. | SYNCHROMEDII (Device) | Food and Beverage | In-kind items and services | $224.83 | General |
| Category: Drug Infusion Systems | ||||||
| 06/14/2023 | Medtronic, Inc. | SYNCHROMEDII (Device) | Food and Beverage | In-kind items and services | $113.52 | General |
| Category: Drug Infusion Systems | ||||||
| 06/14/2023 | Medtronic, Inc. | SYNCHROMEDII (Device) | Food and Beverage | In-kind items and services | $63.65 | General |
| Category: Drug Infusion Systems | ||||||
| 06/14/2023 | Medtronic, Inc. | SYNCHROMEDII (Device) | Travel and Lodging | In-kind items and services | $62.44 | General |
| Category: Drug Infusion Systems | ||||||
| 06/14/2023 | Medtronic, Inc. | SYNCHROMEDII (Device) | Food and Beverage | In-kind items and services | $61.52 | General |
| Category: Drug Infusion Systems | ||||||
| 06/14/2023 | Medtronic, Inc. | SYNCHROMEDII (Device) | Food and Beverage | In-kind items and services | $60.66 | General |
| Category: Drug Infusion Systems | ||||||
| 06/14/2023 | Medtronic, Inc. | SYNCHROMEDII (Device) | Travel and Lodging | In-kind items and services | $36.00 | General |
| Category: Drug Infusion Systems | ||||||
| 06/14/2023 | Medtronic, Inc. | SYNCHROMEDII (Device) | Food and Beverage | In-kind items and services | $19.81 | General |
| Category: Drug Infusion Systems | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 749 | 1,022 | $164,236 | $42,262 |
| 2021 | 9 | 772 | 1,056 | $147,286 | $32,308 |
| 2020 | 8 | 812 | 1,090 | $158,837 | $38,197 |
Total Patients
2,333
Total Services
3,168
Medicare Billing
$112,768
Procedure Codes
25
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 302 | 365 | $110,960 | $27,372 | 24.7% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 59 | 110 | $28,689 | $6,987 | 24.4% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2023 | 292 | 359 | $10,752 | $4,383 | 40.8% |
| 96132 | Evaluation of neuropsychological test, first hour | Office | 2023 | 23 | 23 | $7,045 | $1,878 | 26.7% |
| 20553 | Injection of trigger points, 3 or more muscles | Office | 2023 | 15 | 16 | $2,848 | $578.45 | 20.3% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 11 | 11 | $1,859 | $485.33 | 26.1% |
| 96138 | Administration of psychological or neuropsychological test by technician, first 30 minutes | Office | 2023 | 25 | 25 | $1,817 | $484.25 | 26.7% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 22 | 113 | $265.55 | $93.91 | 35.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 307 | 355 | $107,920 | $22,164 | 20.5% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2021 | 294 | 339 | $10,202 | $4,261 | 41.8% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 29 | 29 | $13,456 | $2,347 | 17.4% |
| 99336 | Established patient assisted living visit, typically 40 minutes | Office | 2021 | 18 | 18 | $7,002 | $1,540 | 22.0% |
| 20553 | Injections of trigger points in 3 or more muscles | Office | 2021 | 27 | 33 | $5,874 | $1,154 | 19.7% |
| G0444 | Annual depression screening, 15 minutes | Office | 2021 | 30 | 30 | $1,091 | $428.10 | 39.2% |
| 99211 | Established patient outpatient visit, minimal presenting problem | Office | 2021 | 24 | 24 | $1,440 | $304.04 | 21.1% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2021 | 24 | 116 | $272.60 | $97.56 | 35.8% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2021 | 19 | 112 | $28.00 | $12.79 | 45.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 360 | 446 | $122,717 | $28,150 | 22.9% |
| 80305 | Testing for presence of drug | Office | 2020 | 303 | 364 | $12,883 | $4,577 | 35.5% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 31 | 31 | $12,566 | $2,844 | 22.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 44 | 45 | $5,767 | $1,414 | 24.5% |
| 20553 | Injections of trigger points in 3 or more muscles | Office | 2020 | 23 | 23 | $4,094 | $884.84 | 21.6% |
| G0444 | Annual depression screening, 15 minutes | Office | 2020 | 16 | 16 | $582.08 | $225.76 | 38.8% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2020 | 23 | 89 | $209.15 | $94.56 | 45.2% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2020 | 12 | 76 | $19.00 | $7.39 | 38.9% |
About Joann Mahan, APRN
Joann Mahan, APRN is a Emergency healthcare provider based in Fort Smith, Arkansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/14/2014. The National Provider Identifier (NPI) number assigned to this provider is 1104225317.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Joann Mahan, APRN has received a total of $3,977 in payments from pharmaceutical and medical device companies, with $257.73 received in 2024. These payments were reported across 109 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($2,548).
As a Medicare-enrolled provider, Mahan has provided services to 2,333 Medicare beneficiaries, totaling 3,168 services with total Medicare billing of $112,768. Data is available for 3 years (2020–2023), covering 25 distinct procedure/service records.
Ad
Practice Information
- Specialty Emergency
- Other Specialties Family
- Location Fort Smith, AR
- Active Since 08/14/2014
- Last Updated 08/27/2015
- Taxonomy Code 163WE0003X
- Entity Type Individual
- NPI Number 1104225317
Products in Payments
- SYNCHROMEDII (Device) $1,992
- NURTEC ODT (Drug) $411.39
- Qutenza (Drug) $280.37
- Dayvigo (Drug) $221.53
- UBRELVY (Drug) $173.99
- Belbuca (Drug) $103.41
- XTAMPZA (Drug) $96.33
- Austedo XR (Drug) $75.89
- RELISTOR (Drug) $73.55
- QULIPTA (Drug) $69.28
- APTIOM (Drug) $51.07
- Movantik (Drug) $43.76
- ZTLido (Drug) $35.31
- KAPSPARGO (Drug) $33.87
- TALTZ (Drug) $33.53
- NUEDEXTA (Drug) $29.88
- XIFAXAN (Drug) $28.00
- BELBUCA (Drug) $27.79
- VRAYLAR (Drug) $26.11
- BAQSIMI (Drug) $23.51
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.